Free Republic

IHU- Méditerranée Infection, Marseille, is a significant French research institute that has continued its work on CV 19. For the record, here are excerpts from some recent work, headlined from threads where such would be buried: EXH 1: >>COVID-IHU #15 Version 1 du 27 Mai 2020 Early diagnosis and management of COVID-19 patients: a real-life cohort study of 3,737 patients, Marseille, France Abstract Background: In our institute in Marseille, France, we proposed early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with hydroxychloroquine and azithromycin (HCQ-AZ) was proposed for the positive cases. Methods: We retrospectively report...

Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744).

Oncologist and hematologist Dr. William Grace joins Laura Ingraham with reaction on 'The Ingraham Angle.' ( CLICK ABOVE LINK FOR THE VIDEO ). See the study here. TITLE: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis Authored by Dr. Harvey Risch at the American Journal of Epidemiology. Abstract More than 1.6 million Americans have been infected with SARS-CoV-2 and >10 times that number carry antibodies to it. High-risk patients presenting with progressing symptomatic disease have only hospitalization treatment with its high mortality. An outpatient treatment that prevents hospitalization is...

'These medications need to be widely available and promoted immediately for physicians to prescribe,' the American Journal of Epidemiology says. prestigious medical journal is criticizing news media coverage of hydroxychlorioquine in the battle against coronavirus, saying there is evidence the anti-malarial drug combined with the antibiotic azithromycin helps in the early stages of outpatient treatment. "These medications need to be widely available and promoted immediately for physicians to prescribe," the American Journal of Epidemiology reported in an article published this week that pushed back against claims the regimen has been dangerous or ineffective in all cases. "Hydroxychloroquine plus azithromycin has...

FRIDAY, May 1, 2020 (HealthDay News) -- A 3-week-old Texas infant in critical condition with COVID-19 was successfully treated and recovered, doctors report.This is one of the first cases of its kind, according to the team of doctors at the University of Texas Health Science Center at Houston (UTHealth).They noted that the initial belief that children aren't at risk of serious illness from COVID-19 has been disproved as more information is gathered on the disease caused by the new coronavirus."We are still so early in the research and data available on COVID-19, and as providers, we need to be aware...

A new clinical treatment trial launched Friday and UW Medicine researchers are looking for COVID-19 patients to test the effectiveness of anti-malaria drug hydroxychloroquine. UW researchers want to enroll 630 people who currently have the COVID-19 virus. Researchers say this particular study looks at COVID-19 patients who do not need to go to the hospital yet. Researchers are testing two combinations. One is hydroxychloroquine. The other is hydroxychloroquine plus azithromycin. Researchers are also using a placebo. UW Medicine is looking for patients in cities nationwide including Boston, Chicago, and New York.

A panel of doctors and experts convened by the National Institutes of Health advised against combining two drugs that have been floated as possible cures for COVID-19, warning of potentially harmful effects. The COVID-19 Treatment Guidelines Panel advised against combining hydroxychloroquine, an anti-malarial drug, and azithromycin, an antibiotic also known as 'Z-Pak,' outside of clinical trials. The panel said there is not enough clinical data to recommend either for or against the use of hydroxychloroquine for the treatment of COVID-19. If hydroxychloroquine is used, clinicians should monitor patients for adverse effects, the panel said, especially heart problems. Hydroxychloroquine and azithromycin...

This was my sister's family Dr. Office response in upstate NY regarding her question for use of Hydroxychloroquine as a treatment for Covid-19. I have "x'd out" private info out of respect for her personal privacy.

It was described as the "magic bullet" to protect against the deadly coronavirus -- a "remarkable clinical phenomenon" that could cure the disease within hours. In the words of San Diego physician Jennings Staley, the drug hydroxychloroquine​, approved to treat conditions ranging from malaria to lupus, was "almost too good to be true." The "COVID-19 Concierge Medicine Pack" offered by Dr. Jennings Staley is seen in this image provided by the US Attorney's Office Southern District of California. CNN has obscured the doctor's phone number. On his website advertising the product, Staley -- whose practice includes Botox injections, tattoo removal,...

Dr. Marc Siegel, a Fox News medical contributor, told “Tucker Carlson Tonight” on Tuesday that his 96-year-old father was recently weak and struggling to breathe but recovered after he was administered an anti-malaria drug and antibiotics. Siegel was discussing hopeful signs that hydroxychloroquine has shown in recent studies when combined with antibiotics for coronavirus treatment. Siegel said his father, who lives in Florida, recently complained about weakness, shortness of breath and feared that he was going to die.

So for what it's worth, this was just posted on a neuro MD site: The author is a triple board certified Neurologist. He has published in Proc Natl Acad Sci U S A. and Cell Mol Neurobiol. He trained at Memorial Sloan Kettering Cancer Center, New York Presbyterian, Hospital for Special Surgery, Montefiore, Northwell and Mount Sinai. He has been in Private Practice for the past 12 years in New York. Surviving COVID-19 with Neurological Involvement from the perspective of a Neurologist "To be honest, it was very scary to go through no matter how much specialized medical training one...

For Charles Vavruska, it was nothing short of a miracle cure. Days after the 53-year-old City Council staffer arrived at New York Presbyterian-Queens hospital barely able to breathe and tested positive for COVID-19, doctors started him on the controversial drug cocktail of hydroxychloroquine, an anti-malarial, and azithromycin, an antibiotic. Although Vavruska said he felt almost immediately better, he wishes the urgent-care doctor he went to see in the early days of his flu-like symptoms in mid-March could have prescribed a similar treatment before he grew progressively worse and ended up in a hospital room, hooked up to an oxygen tank...

Where in the world is Waldo? Oh, wait — wrong meme. Carmen Sandiego? Warmer, but no. The answer is zinc sulfate 220-milligram tablets or capsules suitable for popping like candy for a few days. As we've seen, the mass media has been determinedly ignoring the third leg of Dr. Vladimir Zelenko's treatment trifecta. Still, the word has gotten out, and the stuff appears to be out of stock absolutely everywhere.Forward magazine piece on Dr. Vladimir Zelenko. So! What happens if you get sick enough from coronavirus to seek treatment? Even if your own primary-care doctor is friendly to the hydroychloroquine...

The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, France. A cohort of 1061 COVID-19 patients, treated for at least 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ) combination and a follow-up of at least 9 days was investigated. Key findings are: No cardiac toxicity was observed.  A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%).  A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%) (74-95 years old) and 31 required 10 days of hospitalization...

Over the past three weeks, there's been debate over whether hydroxychloroquine, a drug used for decades to treat malaria, can help ease the symptoms of Wuhan coronavirus. During White House press briefings, reporters have done their best to shoot down the possibility. But doctors around the country and the world are using it and seeing positive results.First, in Los Angeles: Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients."Every patient I've prescribed it to has been very, very ill and within 8 to 12 hours, they were...

by Julio Gonzalez, M.D., J.D. A controversy has arisen regarding the utility of using chloroquine or hydroxychloroquine with azithromycin in the prevention and treatment of COVID-19. On the one hand, there are the purists who maintain that these medications ought not be employed until the proof of their benefits has been established. On the other, some advocate for the aggressive and immediate deployment of these medications. With these two very valid competing arguments proffered by sophisticated scientists and healthcare providers, the question for the rest of us mere mortals is what should we do? The first step in addressing this...

Scott Adams blows up The System. He explains that celebrities get the hydroxychloroquine/Z-Pak regimen upon demand, and tells the peasants how to get it if they need it. Key points: 1. A Covid test is $1000, and you wait five days while drowning in your own snot. 2. The hydroxychloroquine/Z-Pak regimen is $20-$50, you may get a case of diarrhea, and the regimen is five days long.Episode 871 Scott Adams: It's Time to Stop Using an Obama Afghanistan Strategy Against a Virushttps://youtu.be/axDxEeanems?t=1035 Lots of the F-word. Scott is MAD, and he's putting the beatdown on the Elites. "You gotta bring...

On March 9 a team of researchers in China published results showing hydroxychloroquine was effective against the 2019 coronavirus in a test tube. The authors suggested a five-day, 12-pill treatment for Covid-19: two 200-milligram tablets twice a day on the first day followed by one tablet twice a day for four more days. A more recent French study used the drug in combination with azithromycin. Most Americans know azithromycin as the brand name Zithromax Z-Pak, prescribed for upper respiratory infections. The Z-Pak alone doesn’t appear to help fight Covid-19, and the findings of combination treatment are preliminary. But researchers in...

Over the weekend, the Food and Drug Administration (FDA) issued an emergency authorization for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) to treat hospitalized COVID-19 patients. Simultaneously, the Department of Health and Human Services (HHS) announced that Sandoz has donated 30 million doses of HCQ and Bayer one million doses of CQ to the Strategic National

Currently, there is no known cure for the coronavirus pandemic ravaging the globe, but one possible remedy, the antimalarial drug hydroxychloroquine, has received increased attention in recent weeks. A new study aims to confirm whether or not that attention is warranted. The study, which will be conducted by the University of Washington in conjunction with New York University, looks to enroll 2,000 people who are "close contacts of persons with confirmed or pending COVID-19 diagnoses," according to a statement announcing the study. "We currently don’t know if hydroxychloroquine works, but we will learn in as short a timeframe as possible...